Amgen, Inc. (AMGN)
374.75
-0.75
(-0.20%)
USD |
NASDAQ |
Feb 20, 16:00
375.49
+0.74
(+0.20%)
After-Hours: 20:00
Amgen EPS Diluted (Quarterly) : 2.455 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 1.74 |
| Johnson & Johnson | 2.098 |
| Eli Lilly & Co. | 7.024 |
| Merck & Co., Inc. | 1.191 |
| Regeneron Pharmaceuticals, Inc. | 7.857 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.333B |
| Revenue (Quarterly) | 9.896B |
| Total Expenses (Quarterly) | 8.563B |
| Enterprise Value | 248.32B |
| Gross Profit Margin (Quarterly) | 81.91% |
| Profit Margin (Quarterly) | 13.47% |
| Earnings Yield | 3.80% |
| Operating Earnings Yield | 5.05% |
| Normalized Earnings Yield | 4.195 |